title: A new paradigm for multidrug-resistant tuberculosis?
authors.affiliation: New Jersey Medical School Global Tuberculosis Institute, Rutgers University, Newark, NJ, USA.
authors.forename: Lee B
authors.initials: LB
authors.lastname: Reichman
authors.affiliation: Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
authors.forename: H Simon
authors.initials: HS
authors.lastname: Schaaf
authors.affiliation: Department of Infectious Diseases, Galliera Hospital, Genoa, Italy.
authors.forename: Emanuele
authors.initials: E
authors.lastname: Pontali
authors.affiliation: World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy, giovannibattista.migliori@fsm.it.
authors.forename: G B
authors.initials: GB
authors.lastname: Migliori
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D024841:Fluoroquinolones / Q000627:therapeutic use*; D006801:Humans; D055985:Latent Tuberculosis / Q000188:drug therapy*; D008297:Male; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D024841:Fluoroquinolones